Dexcom Inc. Stock
€265.70
Your prediction
Dexcom Inc. Stock
Pros and Cons of Dexcom Inc. in the next few years
Pros
Cons
Performance of Dexcom Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Dexcom Inc. | 1.550% | -12.345% | -34.275% | -10.024% | -44.706% | 148.009% | 322.835% |
Zimmer Holdings | -1.030% | 1.456% | -3.173% | -16.169% | -0.115% | 8.807% | 5.701% |
Becton, Dickinson & Co. | 0.300% | -0.021% | -1.064% | 19.361% | 6.158% | 12.586% | 42.125% |
Dentsply Sirona Inc. | 0.950% | 3.364% | -5.058% | -33.622% | -27.039% | -24.356% | -35.193% |
Comments
News

Dexcom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien, Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and Diabetes Symposium on

Dexcom Announces Upcoming Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor

Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time
DexCom, Inc. has updated its first quarter 2022 earnings call due to technical difficulties with the conference call provider. The conference call will now start at 5:30 p.m. (Eastern Time). The